Algernon Pharmaceuticals AGNPF Stock
Algernon Pharmaceuticals Price Chart
Algernon Pharmaceuticals AGNPF Financial and Trading Overview
| Algernon Pharmaceuticals stock price | 0.05 USD |
| Previous Close | 0.17 USD |
| Open | 0.18 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.17 - 0.18 USD |
| 52 Week Range | 0.15 - 1.33 USD |
| Volume | 21.9K USD |
| Avg. Volume | 15.35K USD |
| Market Cap | 1.99M USD |
| Beta (5Y Monthly) | 0.388167 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
AGNPF Valuation Measures
| Enterprise Value | 1.42M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.45698923 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.243 |
Trading Information
Algernon Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.388167 |
| 52-Week Change | -78.88% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.33 USD |
| 52 Week Low | 0.15 USD |
| 50-Day Moving Average | 0.19 USD |
| 200-Day Moving Average | 0.42 USD |
AGNPF Share Statistics
| Avg. Volume (3 month) | 15.35K USD |
| Avg. Daily Volume (10-Days) | 22.92K USD |
| Shares Outstanding | 11.53M |
| Float | 8.61M |
| Short Ratio | N/A |
| % Held by Insiders | 3.22% |
| % Held by Institutions | 14.39% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 4:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | August 31, 2022 |
| Most Recent Quarter (mrq) | February 28, 2023 |
| Next Fiscal Year End | August 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -53.43% |
| Return on Equity (ttm) | -123.79% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -5851840 USD |
| Net Income Avi to Common (ttm) | -6145317 USD |
| Diluted EPS (ttm) | -0.43 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 220.59K USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.195 |
| Book Value Per Share (mrq) | 0.372 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3648917 USD |
| Levered Free Cash Flow (ttm) | -1088101 USD |
Profile of Algernon Pharmaceuticals
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 601 West Broadway |
| ZIP | V5Z 4C2 |
| Phone | N/A |
| Website | https://algernonpharmaceuticals.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of nonalcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada, Australia, and New Zealand. The company's pipeline includes Ifenprodil, which completed Phase 2 clinical trial for the treatment of idiopathic pulmonary fibrosis and chronic cough; repirinast, which is in preclinical stage for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine, which has completed preclinical stage for the treatment of strokes. The company was formerly known as Breathtec Biomedical, Inc. and changed its name to Algernon Pharmaceuticals Inc. in July 2015. Algernon Pharmaceuticals Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.
Q&A For Algernon Pharmaceuticals Stock
What is a current AGNPF stock price?
Algernon Pharmaceuticals AGNPF stock price today per share is 0.05 USD.
How to purchase Algernon Pharmaceuticals stock?
You can buy AGNPF shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Algernon Pharmaceuticals?
The stock symbol or ticker of Algernon Pharmaceuticals is AGNPF.
Which industry does the Algernon Pharmaceuticals company belong to?
The Algernon Pharmaceuticals industry is Biotechnology.
How many shares does Algernon Pharmaceuticals have in circulation?
The max supply of Algernon Pharmaceuticals shares is 30.27M.
What is Algernon Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Algernon Pharmaceuticals PE Ratio is now.
What was Algernon Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Algernon Pharmaceuticals EPS is -0.01 USD over the trailing 12 months.
Which sector does the Algernon Pharmaceuticals company belong to?
The Algernon Pharmaceuticals sector is Healthcare.